<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.cnbc.com/id/15839135/device/rss/rss.html</title><link>https://www.cnbc.com/id/15839135/device/rss/rss.html</link><description>Individual feed output.</description><lastBuildDate>Thu, 06 Feb 2025 15:21:36 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Shares of Peloton surge 9% as it edges toward profitability, posts better than expected sales</title><link>https://www.cnbc.com/2025/02/06/peloton-pton-q2-2025-earnings.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Peloton has shifted its focus to boosting profitability at the expense of growing sales by cutting marketing and other administraitive costs.</description><pubDate>Thu, 06 Feb 2025 20:09:38 GMT</pubDate></item><item><title>Shares of Coach parent Tapestry spike, as holiday sales soar after merger collapse</title><link>https://www.cnbc.com/2025/02/06/tapestry-tpr-q2-2025-earnings.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Coach's parent company reported the results less than two months after calling off its merger with fashion accessories competitor Capri.</description><pubDate>Thu, 06 Feb 2025 19:01:39 GMT</pubDate></item><item><title>Roblox plummets 14% on disappointing bookings, daily active users miss</title><link>https://www.cnbc.com/2025/02/06/roblox-plummets-on-disappointing-bookings-daily-active-users-miss.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Roblox shares plunged 14% after falling short of Wall Street's bookings and daily active user estimates.</description><pubDate>Thu, 06 Feb 2025 18:50:46 GMT</pubDate></item><item><title>Eli Lilly has its mojo back ahead of a pivotal year for the obesity drug giant</title><link>https://www.cnbc.com/2025/02/06/eli-lilly-has-its-mojo-back-ahead-of-a-pivotal-year-for-the-drug-giant.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>The drugmaker is not perfect, as the past few months showed, but it's still a thoroughbred.</description><pubDate>Thu, 06 Feb 2025 18:45:09 GMT</pubDate></item><item><title>Linde shares whipsaw after earnings, highlighting a crucial lesson for investors</title><link>https://www.cnbc.com/2025/02/06/linde-shares-whipsaw-after-earnings-highlighting-lesson-for-investors.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Management assured us that its outlook is a starting point for the year and not hostage to currency fluctuations.</description><pubDate>Thu, 06 Feb 2025 18:16:37 GMT</pubDate></item></channel></rss>